419
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics

&
Pages 371-384 | Received 27 Dec 2022, Accepted 06 Apr 2023, Published online: 19 Apr 2023

References

  • Akbari E, Parastouei K, Abbaszadeh S. 2022. Physico-chemical and sensory analysis of walnut coated with rose extract and probiotic: a layer-by-layer approach. Food Measure. 16(2):1472–1482.
  • Allegretti JR, Kelly CR, Fischer M, Cohen T, Gerardin Y, Budree S, Khanna S. 2022. CP101, an investigational orally administered microbiome therapeutic, was effective for prevention of recurrent C. difficile infection: results from open-label PRISM-EXT trial. Gastroenterology. 162(7):S143.
  • Allouche R, Dupont S, Charriau A, Gervais P, Beney L, Chambin O. 2018. Optimized tableting for extremely oxygen-sensitive probiotics using direct compression. Int J Pharm. 538(1–2):14–20.
  • Almeida D, Machado D, Sousa S, Seabra CL, Barbosa JC, Andrade JC, Gomes AM, Freitas AC. 2022. Effect of emulsification/internal gelation-based microencapsulation on the viability of Akkermansia muciniphila upon prolonged storage and simulated gastrointestinal passage. Food Hydrocolloids for Health. 2:100084.
  • Amiri S, Nezamdoost-Sani N, Mostashari P, McClements DJ, Marszalek K, Mousavi Khaneghah A. 2022. Effect of the molecular structure and mechanical properties of plant-based hydrogels in food systems to deliver probiotics: an updated review. Crit Rev Food Sci Nutr. 62:1–28.
  • Andrade JC, Almeida D, Domingos M, Seabra CL, Machado D, Freitas AC, Gomes AM. 2020. Commensal obligate anaerobic bacteria and health: production, storage, and delivery strategies. Front Bioeng Biotechnol. 8:550.
  • Anselmo AC, McHugh KJ, Webster J, Langer R, Jaklenec A. 2016. Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv Mater. 28(43):9486–9490.
  • Argin S, Kofinas P, Lo YM. 2014. The cell release kinetics and the swelling behavior of physically crosslinked xanthan-chitosan hydrogels in simulated gastrointestinal conditions. Food Hydrocolloids. 40:138–144.
  • Asgari S, Pourjavadi A, Licht TR, Boisen A, Ajalloueian F. 2020. Polymeric carriers for enhanced delivery of probiotics. Adv Drug Deliv Rev. 161–162:1–21.
  • Baird R, Omlin A, Kiemle-Kallee J, Fiedler U, Zitt C, Feurstein D, Herbst J, Dawson K, Vom Baur E, Stumpp M, et al. 2018. MP0274-CP101: a phase 1, first-in-human, single-arm, multi-center, open-label, dose escalation study to assess safety, tolerability, and pharmacokinetics of MP0274 in patients with advanced HER2-positive solid tumors. Cancer Res. 78(4_Suppl):OT1-03-02.
  • Barbosa JC, Almeida D, Machado D, Sousa S, Freitas AC, Andrade JC, Gomes AM. 2022. Spray-drying encapsulation of the live biotherapeutic candidate Akkermansia muciniphila DSM 22959 to survive aerobic storage. Pharmaceuticals. 15(5):628.
  • Basso PJ, Saraiva Camara NO, Sales-Campos H. 2019. Microbial-based therapies in the treatment of inflammatory bowel disease–an overview of human studies. Front Pharmacol. 9:1571.
  • Boesmans L, Valles-Colomer M, Wang J, Eeckhaut V, Falony G, Ducatelle R, Van Immerseel F, Raes J, Verbekem K. 2018. Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers. Msystems. 3(6):e00094–e00118.
  • Bollom MA, Clark S, Acevedo NC. 2021. Edible lecithin, stearic acid, and whey protein bigels enhance survival of probiotics during in vitro digestion. Food Biosci. 39:100813.
  • Ching SH, Bansal N, Bhandari B. 2017. Alginate gel particles-a review of production techniques and physical properties. Crit Rev Food Sci Nutr. 57(6):1133–1152.
  • Chinna Meyyappan A, Milev R. 2020. The safety, efficacy, and tolerability of microbial ecosystem therapeutic-2 in people with major depression and/or generalized anxiety disorder: protocol for a phase 1, open-label study. JMIR Res Protoc. 9(6):e17223.
  • Chinna Meyyappan A, Sgarbossa C, Vazquez G, Bond DJ, Muller DJ, Milev R. 2021. The safety and efficacy of microbial ecosystem therapeutic-2 in people with major depression: protocol for a phase 2, double-blind, placebo-controlled study. JMIR Res Protoc. 10(9):e31439.
  • Cordaillat-Simmons M, Rouanet A, Pot B. 2020. Live biotherapeutic products: the importance of a defined regulatory framework. Exp Mol Med. 52(9):1397–1406.
  • Deng L, Dong H, Dong A, Zhang J. 2015. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity. Eur J Pharm Biopharm. 97(Pt A):107–117.
  • Ding S, Serra CA, Vandamme TF, Yu W, Anton N. 2019. Double emulsions prepared by two-step emulsification: history, state-of-the-art and perspective. J Control Release. 295:31–49.
  • Dong Y, Xu T, Xiao G, Hu Z, Chen J. 2022. Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Front Bioeng Biotechnol. 10:909591.
  • Effendi SSW, Ng IS. 2022. Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917. Crit Rev Microbiol. 1–17. DOI:10.1080/1040841X.2022.2109405.
  • Fuenzalida C, Dufeu MS, Poniachik J, Roblero JP, Valenzuela-Perez L, Beltran CJ. 2021. Probiotics-based treatment as an integral approach for alcohol use disorder in alcoholic liver disease. Front Pharmacol. 12:729950.
  • Gagliarini N, Diosma G, Garrote GL, Abraham AG, Piermaria J. 2019. Whey protein-kefiran films as driver of probiotics to the gut. LWT. 105:321–328.
  • Ganesh BP, Versalovic J. 2015. Luminal conversion and immunoregulation by probiotics. Front Pharmacol. 6:269.
  • Gupta VK, Assmus MW, Beckert TE, Price JC. 2001. A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int J Pharm. 213(1–2):93–102.
  • Hagihara M, Yamashita R, Matsumoto A, Mori T, Inagaki T, Nonogaki T, Kuroki Y, Higashi S, Oka K, Takahashi M, et al. 2019. The impact of probiotic Clostridium butyricum MIYAIRI 588 on murine gut metabolic alterations. J Infect Chemother. 25(8):571–577.
  • Hagihara M, Yamashita R, Matsumoto A, Mori T, Kuroki Y, Kudo H, Oka K, Takahashi M, Nonogaki T, Yamagishi Y, et al. 2018. The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue. Anaerobe. 54:8–18.
  • Harshitha K, Kulkarni PK, Vaghela R, Varma VNSK, Deshpande DR, Hani U. 2015. Probiotic and prebiotic-probiotic PEC microparticles for sustaining and enhancing intestinal probiotic growth. Curr Drug Deliv. 12(3):299–307.
  • Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P. 2021. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol. 70(10):1–12.
  • Heavey MK, Durmusoglu D, Crook N, Anselmo AC. 2022. Discovery and delivery strategies for engineered live biotherapeutic products. Trends Biotechnol. 40(3):354–369.
  • Heidebach T, Först P, Kulozik U. 2009. Transglutaminase-induced caseinate gelation for the microencapsulation of probiotic cells. Int Dairy J. 19(2):77–84.
  • Heidebach T, Först P, Kulozik U. 2012. Microencapsulation of probiotic cells for food applications. Crit Rev Food Sci Nutr. 52(4):291–311.
  • Hirsch E, Pantea E, Vass P, Domján J, Molnár M, Suhajda Á, Andersen SK, Vigh T, Verreck G, Marosi GJ, et al. 2021. Probiotic bacteria stabilized in orally dissolving nanofibers prepared by high-speed electrospinning. Food Bioprod Process. 128:84–94.
  • Hu C-MJ, Fang RH, Zhang L. 2012. Erythrocyte-inspired delivery systems. Adv Healthcare Mater. 1(5):537–547.
  • Huang C, Wang F-B, Liu L, Jiang W, Liu W, Ma W, Zhao H. 2021. Hypoxic tumor radiosensitization using engineered probiotics. Adv Healthcare Mater. 10(10):2002207.
  • Jacobsen C, Garcia-Moreno PJ, Mendes AC, Mateiu RV, Chronakis IS. 2018. Use of electrohydrodynamic processing for encapsulation of sensitive bioactive compounds and applications in food. Annu Rev Food Scie Technol. 9:525–549.
  • Jones RM, Neish AS. 2014. Redox signaling mediates symbiosis between the gut microbiota and the intestine. Gut Microbes. 5(2):250–253.
  • Kamguyan K, Torp AM, Christfort JF, Guerra PR, Licht TR, Nielsen LH, Zor K, Boisen A. 2021. Colon-specific delivery of bioactive agents using genipin-cross-linked chitosan coated microcontainers. ACS Appl Bio Mater. 4(1):752–762.
  • Kao D, Wong K, Franz R, Cochrane K, Sherriff K, Chui L, Lloyd C, Roach B, Bai AD, Petrof EO, et al. 2021. The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial. Lancet Gastroenterol Hepatol. 6(4):282–291.
  • Kim H, Gryllos I, Li C, Brownell D, Krueger T. 2022. Efficacy and safety of B244, a live topical biotherapeutic, in patients with pruritus associated with mild-to-moderate atopic dermatitis. Br J Dermatol. 187(3):E133.
  • Kim W-S, Cho C-S, Hong L, Han GG, Kil BJ, Kang S-K, Kim D-D, Choi Y-J, Huh CS. 2019. Oral delivery of probiotics using pH-sensitive phthalyl inulin tablets. J Microbiol Biotechnol. 29(2):200–208.
  • Klayraung S, Viernstein H, Okonogi S. 2009. Development of tablets containing probiotics: effects of formulation and processing parameters on bacterial viability. Int J Pharm. 370(1–2):54–60.
  • Kosakova D, Scheer P, Lata J, Doubek J. 2007. Influence of the Escherichia coli Nissle 1917 strain on complications of chronic experimental liver damage. Vet Med. 52(3):121–129.
  • Kurapati R, Groth TW, Raichur AM. 2019. Recent developments in layer-by-layer technique for drug delivery applications. ACS Appl Bio Mater. 2(12):5512–5527.
  • Laelorspoen N, Wongsasulak S, Yoovidhya T, Devahastin S. 2014. Microencapsulation of Lactobacillus acidophilus in zein-alginate core-shell microcapsules via electrospraying. J Funct Foods. 7:342–349.
  • Lata J, Novotný I, Príbramská V, Juránková J, Fric P, Kroupa R, Stibůrek O. 2007. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol. 19(12):1111–1113.
  • Leopold CS. 1999. Coated dosage forms for colon-specific drug delivery. Pharm Sci Technol Today. 2(5):197–204.
  • Li J, Huo M, Wang J, Zhou J, Mohammad JM, Zhang Y, Zhu Q, Waddad AY, Zhang Q. 2012. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 33(7):2310–2320.
  • Lim L-T, Mendes AC, Chronakis IS. 2019. Electrospinning and electrospraying technologies for food applications. Adv Food Nutr Res. 88:167–234.
  • Lin Y, Gao X, Yue J, Fang Y, Shi J, Meng L, Clayton C, Zhang X-X, Shi F, Deng J, et al. 2023. A soil-inspired dynamically responsive chemical system for microbial modulation. Nat Chem. 15(1):119–128.
  • Liu H, Cui SW, Chen M, Li Y, Liang R, Xu F, Zhong F. 2019. Protective approaches and mechanisms of microencapsulation to the survival of probiotic bacteria during processing, storage and gastrointestinal digestion: a review. Crit Rev Food Sci Nutr. 59(17):2863–2878.
  • Liu L, Yao W, Rao Y, Lu X, Gao J. 2017. pH-responsive carriers for oral drug delivery: challenges and opportunities of current platforms. Drug Deliv. 24(1):569–581.
  • Liu Y, Sun Y, Sun L, Wang, Y, Rizwan-Ur-Rehman. 2016. In vitro and in vivo study of sodium polyacrylate grafted alginate as microcapsule matrix for live probiotic delivery. J Funct Foods. 24:429–437.
  • Liu Z, Zhou X, Wang W, Gu L, Hu C, Sun H, Xu C, Hou J, Jiang Z. 2022. Lactobacillus paracasei 24 attenuates lipid accumulation in high-fat diet-induced obese mice by regulating the gut microbiota. J Agric Food Chem. 70(15):4631–4643.
  • Machado D, Domingos M, Barbosa JC, Almeida D, Andrade JC, Freitas AC, Gomes AM. 2022. Exploring freeze-drying as strategy to enhance viability of Faecalibacterium duncaniae DSM 17677 upon aerobic storage and gastrointestinal conditions. Pharmaceutics. 14(12):2735.
  • Marcial-Coba MS, Cieplak T, Cahu TB, Blennow A, Knochel S, Nielsen DS. 2018. Viability of microencapsulated Akkermansia muciniphila and Lactobacillus plantarum during freeze-drying, storage and in vitro simulated upper gastrointestinal tract passage. Food Funct. 9(11):5868–5879.
  • Mendes AC, Chronakis IS. 2021. Electrohydrodynamic encapsulation of probiotics: a review. Food Hydrocoll. 117:106688.
  • Meyyappan AC, Milev R. 2021. A phase 2, double-blind, placeco-controlled study of the safety and efficacy of microbial ecosystem therapeutic-2 (MET-2) in patients with major depression: protocol and preliminary results. J Neurol Sci. 429:55–55.
  • Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, Okazaki S, Yamashita S, Miura S, Miki H, et al. 2018. Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: a prospective open-label trial. Clin Neuropharmacol. 41(5):151–155.
  • Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-Lubio R, Silby MW, Bang C, McCormick BA, Bucci V. 2022. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes. 14(1):2127633.
  • Neish AS. 2009. Microbes in Gastrointestinal Health and Disease. Gastroenterology. 136(1):65–80.
  • Nougayrede J-P, Chagneau CV, Motta J-P, Bossuet-Greif N, Belloy M, Taieb F, Gratadoux JJ, Thomas M, Langella P, Oswald E. 2021. A toxic friend: genotoxic and mutagenic activity of the probiotic strain Escherichia coli Nissle 1917. mSphere. 6(4):e0062421.
  • O’Toole PW, Marchesi JR, Hill C. 2017. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2(5):17057.
  • Olson JK, Rager TM, Navarro JB, Mashburn-Warren L, Goodman SD, Besner GE. 2016. Harvesting the benefits of biofilms: a novel probiotic delivery system for the prevention of necrotizing enterocolitis. J Pediatr Surg. 51(6):936–941.
  • Pant S, Shah A, Msaouel P, Campbell M, Tu S-M, Gao J, Blumenschein G, Mott F, Le X, Altan M. 2020a. A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors. J ImmunoTher Cancer. 8: A229.
  • Pant S, Shah A, Msaouel P, Campbell M, Tu S-M, Gao J, Blumenschein G, Mott F, Le X, Altan M, et al. 2020b. Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs). J ImmunoTher Cancer. 8: A173.
  • Peres LB, dos Anjos RS, Tappertzhofen LC, Feuser PE, de Araujo PHH, Landfester K, Sayer C, Munoz-Espi R. 2018. pH-responsive physically and chemically cross-linked glutamic-acid-based hydrogels and nanogels. Eur Polym J. 101:341–349.
  • Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A, Eid J, Gines J, Iyer M, Justice N, et al. 2020. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diab Res Care. 8(1):e001319.
  • Prakash S, Tomaro-Duchesneau C, Saha S, Cantor A. 2011. The Gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells. J Biomed Biotechnol. 2011:1–12.
  • Qin X-S, Luo Z-G, Li X-L. 2021. An enhanced pH-sensitive carrier based on alginate-Ca-EDTA in a set-type W-1/O/W-2 double emulsion model stabilized with WPI-EGCG covalent conjugates for probiotics colon-targeted release. Food Hydrocoll. 113:106460.
  • Qiu K, Anselmo AC. 2021. Batch culture formulation of live biotherapeutic products. Adv Therap. 4(2):2000226.
  • Qiu K, Huang Y, Anselmo AC. 2021. Polymer and crosslinker content influences performance of encapsulated live biotherapeutic products. Cell Mol Bioeng. 14(5):487–499.
  • Quintana G, Gerbino E, Alves P, Simoes PN, Rua ML, Fucinos C, Gomez-Zavaglia A. 2021. Microencapsulation of Lactobacillus plantarum in W/O emulsions of okara oil and block-copolymers of poly(acrylic acid) and pluronic using microfluidic devices. Food Res Int. 140:110053.
  • Quintana G, Simoes MG, Hugo A, Alves P, Ferreira P, Gerbino E, Simoes PN, Gomez-Zavaglia A. 2017. Layer-by-layer encapsulation of Lactobacillus delbrueckii subsp Bulgaricus using block-copolymers of poly(acrylic acid) and pluronic for safe release in gastro-intestinal conditions. J Funct Foods. 35:408–417.
  • Raise A, Dupont S, Iaconelli C, Caliri C, Charriau A, Gervais P, Chambin O, Beney L. 2020. Comparison of two encapsulation processes to protect the commensal gut probiotic bacterium Faecalibacterium prausnitzii from the digestive tract. J Drug Delivery Sci Technol. 56:101608.
  • Ramos PE, Cerqueira MA, Teixeira JA, Vicente AA. 2018. Physiological protection of probiotic microcapsules by coatings. Crit Rev Food Sci Nutr. 58(11):1864–1877.
  • Ravi V, Pramod Kumar, TM, Siddaramaiah. 2008. Influence of natural polymer coating on novel colon targeting drug delivery system. J Mater Sci Mater Med. 19(5):2131–2136.,
  • Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, et al. 2016. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J Gastroenterol. 22(24):5505–5511.
  • Schrezenmeir J, de Vrese M. 2001. Probiotics, prebiotics, and synbiotics–approaching a definition. Am J Clin Nutr. 73(2 Suppl):361S–364S.
  • Shah MA, Bang Y-J, Lordick F, Alsina M, Chen M, Hack SP, Bruey JM, Smith D, McCaffery I, Shames DS, et al. 2017. Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in HER2-negative, MET-positive gastroesophageal adenocarcinoma: the METGastric randomized clinical trial. JAMA Oncol. 3(5):620–627.
  • Singh B, Maharjan S, Jiang T, Kang S-K, Choi Y-J, Cho C-S. 2015. Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials. 59:144–159.
  • Sinha VR, Kumria R. 2001. Polysaccharides in colon-specific drug delivery. Int J Pharm. 224(1–2):19–38.
  • Soundararajan M, von Bünau R, Oelschlaeger TA. 2019. K5 capsule and lipopolysaccharide are important in resistance to T4 phage attack in probiotic E. coli strain Nissle 1917. Front Microbiol. 10:2783.
  • Stoeva MK, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M, McMurdie PJ, Kolterman O, Eid J. 2021. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes. 13(1):1–28.
  • Talebian S, Schofield T, Valtchev P, Schindeler A, Kavanagh JM, Adil Q, Dehghani F. 2022. Biopolymer-based multilayer microparticles for probiotic delivery to colon. Adv Healthcare Mater. 11(11):e2102487.
  • Tang Z, Wang Y, Podsiadlo P, Kotov NA. 2006. Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering. Adv Mater. 18(24):3203–3224.
  • Tian T, Xu B, Qin Y, Fan L, Chen J, Zheng P, Gong X, Wang H, Bai M, Pu J, et al. 2019. Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice. Biochem Biophys Res Commun. 516(2):430–436.
  • Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, et al. 2022. Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors. Oncoimmunology. 11(1):2081010.
  • Tomita Y, Ikeda T, Sakata S, Saruwatari K, Sato R, Iyama S, Jodai T, Akaike K, Ishizuka S, Saeki S, et al. 2020. Association of probiotic Clostridium butyricum therapy with survival and response to immune checkpoint blockade in patients with lung cancer. Cancer Immunol Res. 8(10):1236–1242.
  • van der Ark KCH, Nugroho ADW, Berton-Carabin C, Wang C, Belzer C, de Vos WM, Schroen K. 2017. Encapsulation of the therapeutic microbe Akkermansia muciniphila in a double emulsion enhances survival in simulated gastric conditions. Food Res Int. 102:372–379.
  • Vargason AM, Anselmo AC. 2020. Evaluation of surface modified live biotherapeutic products for oral delivery. ACS Biomater Sci Eng. DOI:10.1021/acsbiomaterials.0c01405.
  • Wang GQ, Liu J, Xia YJ, Ai LZ. 2021. Probiotics-based interventions for diabetes mellitus: a review. Food Biosci. 43:101172.
  • Wang M, Yang J, Li M, Wang Y, Wu H, Xiong L, Sun Q. 2019. Enhanced viability of layer-by-layer encapsulated Lactobacillus pentosus using chitosan and sodium phytate. Food Chem. 285:260–265.
  • Wang M, Zang Y, Hong K, Zhao X, Yu C, Liu D, An Z, Wang L, Yue W, Nie G. 2021. Preparation of pH-sensitive carboxymethyl cellulose/chitosan/alginate hydrogel beads with reticulated shell structure to deliver Bacillus subtilis natto. Int J Biol Macromol. 192:684–691.
  • Wang X, Cao Z, Zhang M, Meng L, Ming Z, Liu J. 2020. Bioinspired oral delivery of gut microbiota by self-coating with biofilms. Sci Adv. 6(26):eabb1952.
  • Wang X, Gao S, Yun S, Zhang M, Peng L, Li Y, Zhou Y. 2022. Microencapsulating alginate-based polymers for probiotics delivery systems and their application. Pharmaceuticals. 15(5):644.
  • Wu Q-X, Xu X, Xie Q, Tong W-Y, Chen Y. 2016. Evaluation of chitosan hydrochloride-alginate as enteric micro-probiotic-carrier with dual protective barriers. Int J Biol Macromol. 93(Pt A):665–671.
  • Xiao Y, Lu C, Liu Y, Kong L, Bai H, Mu H, Li Z, Geng H, Duan J. 2020. Encapsulation of Lactobacillus rhamnosus in hyaluronic acid-based hydrogel for pathogen-targeted delivery to ameliorate enteritis. ACS Appl Mater Interfaces. 12(33):36967–36977.
  • Xie C, Bian Y, Feng H, Zhao Y, Wang L, Li Y, Zhang D, Tian Y, Li L, Chang S, et al. 2019. Reversal of ciprofloxacin-induced testosterone reduction by probiotic microbes in mouse testes. Gen Comp Endocrinol. 284:113268.
  • Zaeim D, Sarabi-Jamab M, Ghorani B, Kadkhodaee R. 2019. Double layer co-encapsulation of probiotics and prebiotics by electro-hydrodynamic atomization. LWT. 110:102–109.
  • Zhao H, Lu Z, Lu Y. 2022. The potential of probiotics in the amelioration of hyperuricemia. Food Funct. 13(5):2394–2414.
  • Zhao M, Huang X, Zhang H, Zhang Y, Ganzle M, Yang N, Nishinari K, Fang Y. 2020. Probiotic encapsulation in water-in-water emulsion via heteroprotein complex coacervation of type-A gelatin/sodium caseinate. Food Hydrocoll. 105:105790.
  • Zhao Y, Li X, Zhao X, Yang Y, Li H, Zhou X, Yuan W. 2017. Asymmetrical polymer vesicles for drug delivery and other applications. Front Pharmacol. 8:374.
  • Zhu L-F, Chen X, Ahmad Z, Peng Y, Chang M-W. 2020. A core-shell multi-drug platform to improve gastrointestinal tract microbial health using 3D printing. Biofabrication. 12(2):025026.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.